TissueLink Versus SEAMGUARD After Distal Pancreatectomy

Launched by MAYO CLINIC · Jan 19, 2010

Keywords

ClinConnect Summary

The objective of this trial is to compare the effectiveness of TissueLink closure of pancreatic stump after distal pancreatectomy to that of SEAMGUARD reinforced stapler closure.

Distal pancreatectomy is performed for a broad variety of indications including benign and malignant conditions. Specifically, distal pancreatectomy refers to resection of the portion of pancreas to the left of the superior mesenteric vein/portal vein trunk, excluding the duodenum and distal bile duct. Pancreatic duct leak at the resection margin is one of the most common complications of distal pancreatectomy. Th...

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • 1. Age equal or above 18 years
• • 2. Accepted for elective distal pancreatectomy for any indication
• Exclusion from randomization process:
• • Thickness of pancreas on preoperative CT scan images \> 2.5 cm at the site of expected transection in anterior-posterior diameter. This will be reviewed by the surgeon the day before the surgeon sees the patient to predetermine the appropriateness of the patient for the study.
• General study exclusion criteria:
• • 1. Current immunosuppressive therapy
• • 2. Chemotherapy within 2 weeks before operation
• • 3. Bevacizumab (Avastin™) treatment not completed at least 6 weeks before operation
• • 4. Radiotherapy before operation
• • 5. Inability to follow the instructions given by the investigator
• • 6. Lack of compliance
• • 7. Persons unable or unwilling to give informed consent to participate in this study
• • 8. Pregnant women
• • 9. Prisoners
• • 10. Institutionalized individuals